Full-Time

Senior Production Engineer

Posted on 11/8/2025

Deadline 12/18/27
Waters Corporation

Waters Corporation

10,001+ employees

Analytical instruments, software, and services provider

No salary listed

Franklin, MA, USA

In Person

Category
Process Engineering
Required Skills
SAP Products
Assembly
Requirements
  • 3 - 6 years of relevant work experience in a manufacturing environment.
  • Exposure to multiple types of manufacturing equipment including but not limited to CNC machining centers (milling, turning, Swiss), robotics, automation cells, and assembly equipment.
  • CNC machining and G Code.
  • Good knowledge of process development.
  • Experience in the use of hand tools and inspection equipment such as vernier calipers, dial indicators, gages, etc.
  • Excellent written and oral communication skills.
  • Excellent attention to detail.
  • Ability to multi-task and perform a wide range of activities.
  • Ability to work under a timeline with focus, urgency and accountability.
  • Ability to solve basic to moderate technical problems.
  • Strong computer experience including MS Office.
  • Understanding of 5S & Lean Principles.
  • Excellent teamwork and collaboration across departments.
  • Ability to work in a machine shop environment.
  • SAP experience.
Responsibilities
  • Generate CNC programs for milling, turning and Swiss machines.
  • Write clear and detailed Operating Procedures and Processes for manufactured/assembled components.
  • Create bills of material, routings, and cost estimates for new products and updates to existing products and processes.
  • Conceptualize and design fixturing and tooling required in a manufacturing environment.
  • Evaluate non-conforming product and implement corrective actions through root cause analysis.
  • Implementation of cost cutting ideas by reducing waste and processing.
  • Support implementation of Lean Manufacturing, 5S, and SPC in manufacturing areas.
  • Collaborate with the Quality and Production teams to ensure smooth implementation of processes.
  • Train production staff on new processes and provide technical support where required.
  • Ensure compliance with safety, health, and environmental regulations in all processes.
Desired Qualifications
  • Bachelor’s degree in Manufacturing, Mechanical or Industrial Engineering preferred.
  • Vocational trade school education preferred.

Waters Corporation provides analytical system solutions, software, and services for scientists across biopharma, clinical research, forensics, life science research, food and beverage, and environmental sectors. Its products include high-performance analytical instruments like the BioAccord System, paired with software and ongoing support to enable precise, reproducible results. The company operates by selling instruments and software and offering maintenance and services to enhance user experience and reliability. Compared to competitors, Waters offers an integrated package of hardware, software, and service across multiple markets, focused on delivering accurate analyses and end-to-end workflow solutions rather than just standalone devices. Its goal is to unlock the potential of science by solving problems that affect human health and well-being.

Company Size

10,001+

Company Stage

IPO

Headquarters

Milford, Connecticut

Founded

1958

Simplify Jobs

Simplify's Take

What believers are saying

  • BD acquisition adds diagnostics scale and cross-sell opportunities.
  • New 2026 launches expand into GLP-1, LNP, spatial omics, and sepsis testing.
  • China biopharma growth and replacement cycles support continued instrument demand.

What critics are saying

  • Thermo Fisher's scale pressures pricing and share in instrument refresh cycles.
  • BD integration can delay synergies and dilute margin expansion through 2026.
  • Adoption of new diagnostics and bioseparation products depends on reimbursement and validation.

What makes Waters Corporation unique

  • Waters sells integrated chromatography, mass spectrometry, software, and service platforms.
  • Its portfolio targets regulated, high-volume testing across biopharma, diagnostics, and environmental analysis.
  • Recent launches emphasize faster characterization of complex biologics and clinical workflows.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Waters Corporation who can refer or advise you

Benefits

Hybrid Work Options

Growth & Insights and Company News

Headcount

6 month growth

2%

1 year growth

2%

2 year growth

0%
PR Newswire
Apr 14th, 2026
Waters launches omniDAWN MALS detector for UHPLC, enabling 4x faster analysis of large molecules

Waters Corporation has launched the omniDAWN Multi-Angle Light Scattering Photometer, the first extended-range MALS detector designed for ultra high performance liquid chromatography workflows. The device features 18 detection angles and delivers chromatographic run times up to four times faster than conventional methods. The photometer extends UPLC-compatible sizing tenfold, from approximately 50 to 500 nanometres in radius, enabling characterisation of complex molecules including protein aggregates, viral vectors and lipid nanoparticles. It achieves a 10-fold improvement in absolute molar mass measurements whilst reducing sample consumption by 30–50% and solvent use by roughly 40%. The device integrates with Waters UPLC systems and is powered by ASTRA software, supporting analysis across drug discovery, development and quality control. The omniDAWN photometer will be available globally in summer 2026.

PR Newswire
Apr 8th, 2026
Waters gains FDA clearance for at-home cervical cancer screening kit with HPV assay

Waters Corporation has received FDA clearance for the Onclarity HPV Self-Collection Kit and approval for the BD Onclarity HPV Assay with extended genotyping for at-home use. The kit enables cervical cancer screening from home, addressing barriers that prevent many individuals from routine testing. Approximately 60% of cervical cancer cases occur in unscreened or under-screened individuals. The BD Onclarity HPV Assay is the only FDA-approved test identifying six individual HPV genotypes and three pooled groups, making it the most comprehensive screening tool available in the US. The kit will be available by prescription in coming months and is covered by private insurance, Medicaid and Medicare. Waters is establishing partnerships for broader nationwide access, with patients able to collect samples at home and mail them to laboratories for processing.

Paul Hastings LLP
Mar 23rd, 2026
Waters Corporation subsidiary raises $3.5B through senior notes offering

Paul Hastings advised underwriters including Barclays Capital, Citigroup Global Markets and J.P. Morgan Securities in a $3.5 billion senior notes offering by Augusta SpinCo Corporation, a Waters Corporation subsidiary. The SEC-registered offering comprises five tranches of senior notes maturing between 2027 and 2036, with interest rates ranging from 4.321% to 5.245%. The notes are guaranteed by Waters and certain subsidiaries. Partner Jeff Ramsay led the Paul Hastings team, which included partners Morgan Bale, Ismael Duran and Daniel Nicholas, along with several associates.

Yahoo Finance
Mar 19th, 2026
Waters Corporation stock down 22.8% year-on-year, underperforming Dow's 11.2% rise

Waters Corporation (WAT), a leading scientific instruments manufacturer, is underperforming the Dow Jones Industrial Average significantly. The stock trades 28.8% below its 52-week high of $414.15 and has declined 22.3% year-to-date, compared to the Dow's 3.8% decline. The Milford, Massachusetts-based company, with a market cap of $28.9 billion, specialises in analytical technologies including liquid chromatography and mass spectrometry for pharmaceutical, life sciences and industrial applications. Despite reporting solid fourth-quarter results with revenue of $932 million, up 7% year-over-year, and adjusted earnings per share rising 10% to $4.53, investor sentiment has soured. Cautious first-quarter guidance and concerns over its acquisition of Becton Dickinson's biosciences unit, which is underperforming expectations, have weighed on the stock.

Yahoo Finance
Mar 17th, 2026
Waters Corporation Q4 results mixed as research tools sector faces 20.9% share price decline

Waters Corporation reported Q4 revenues of $932.4 million, down 45.4% year on year, meeting analysts' expectations. The analytical instruments manufacturer delivered mixed results, with next quarter's revenue guidance exceeding expectations but earnings per share guidance falling short. The research tools and consumables sector reported a satisfactory Q4 overall, with the 10 tracked stocks beating revenue consensus estimates by 1.2%. However, share prices have struggled, declining 20.9% on average since latest earnings results. Founded in 1958, Waters develops analytical instruments, software and consumables for liquid chromatography, mass spectrometry and thermal analysis. CEO Udit Batra highlighted the company achieved high single-digit revenue growth and double-digit adjusted EPS growth in 2025, with momentum expected to continue into 2026.

INACTIVE